LifeVantage Names Terrence Moorehead CEO Amid Leadership Transition
Event summary
- Terrence Moorehead appointed as President and CEO of LifeVantage, effective August 5, 2026.
- Moorehead brings 25 years of experience in direct selling and consumer products, including a 45% revenue increase at Nature’s Sunshine Products.
- Steve Fife, current CEO, to retire on April 30, 2026, with Michael Beindorff serving as Interim CEO until Moorehead’s start.
- LifeVantage focuses on nutrigenomics, with products like Protandim® and TrueScience®.
- Board highlights Moorehead’s track record in brand revitalization and financial performance.
The big picture
LifeVantage’s appointment of Terrence Moorehead as CEO underscores its focus on strategic transformation and growth. Moorehead’s background in revitalizing brands and accelerating customer growth in the direct selling sector positions him to drive LifeVantage’s next phase of expansion. The transition follows Steve Fife’s retirement, marking a significant shift in leadership for the health and wellness company.
What we're watching
- Execution Risk
- How Moorehead’s strategy will translate to LifeVantage’s unique business model and product portfolio.
- Growth Strategy
- Whether Moorehead can replicate his past success in scaling revenue and EBITDA at LifeVantage.
- Leadership Continuity
- The effectiveness of the interim leadership team in maintaining momentum during the transition period.
Related topics